The discovery of this variant is highly relevant, as previous studies have shown that PTCH1 could serve as a potential biomarker for distinguishing between CRC cases with high and low metastatic risk, with an inverse correlation to PTCH1 protein expression levels (53). The gene discussed is PTCH1; the disease is colorectal carcinoma.